Fig. 2: Kaplan–Meier plots for disease-free survival in patients with stage II/III CRC according to BRAF mutation status. | Modern Pathology

Fig. 2: Kaplan–Meier plots for disease-free survival in patients with stage II/III CRC according to BRAF mutation status.

From: Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation

Fig. 2

Patients are grouped into (a) individuals with mucinous tumours, (b) individuals with tumours with a mucinous component and (c) individuals with non-mucinous tumours. WT wild-type, MUT mutated; *p < 0.050.

Back to article page